In an extensive feature recently published on the ynet news site, Gil Horsky, a prominent food industry expert and venture capital investor, was interviewed regarding the dramatic shifts occurring in the global market. Horsky explains how the rise of new weight-loss drugs (such as Ozempic) is compelling even massive chains like McDonald’s to recalibrate their menus and business strategies.
During the interview, Horsky noted that international corporations fear significant losses if they maintain their traditional marketing approaches. “For years, food companies were used to producing low-cost products with relatively thin margins,” he points out. “Today, they aim to move up the value chain and develop products with higher value.” The shift is moving from a “more for less” model to “less but better.”
Horsky emphasizes that this revolution is an existential necessity in an ever-changing market. Modern consumers are no longer seeking just momentary satiety; they are striving for a balanced lifestyle. According to Horsky, companies that fail to integrate science and technology into their offerings will eventually find themselves left off the modern consumer’s plate.